September 24, 2013 – Edwards Lifesciences Corp. announced a new post-hoc data analysis from The PARTNER Trial ...
Structural Heart
This structural heart channel includes news, videos, podcasts and other content related to diagnosis and treatment of structural heart disease. Topics covered include heart valve repair and replacement, transcatheter aortic valve replacement (TAVR), transcatheter mitral valve replacement (TMVR), transcatheter tricuspid valve replacement (TTVR), left atrial appendage (LAA) occlusion, heart failure interventional device therapies, and closing holes in the heart using, including occlusion of atrial septal defects (ASDs), ventricular septal defects (VSDs) and patent foramen ovales (PFOs).
September 19, 2013 – Boston Scientific reported favorable six-month results from the first 60 patients enrolled in the ...
September 19, 2013 – JenaValve Technology Inc. has received CE (Conformite Europeenne) mark approval from European ...
As medical advancements continue to push the boundaries of what is possible in the field of structural heart ...
September 16, 2013 — The injunction against sales of Medtronic's transcatheter heart valves in Germany — issued in a ...
There is no shortage of debate among interventional cardiologists over whether vascular closure devices should be used ...

September 11, 2013 — Direct Flow Medical Inc. announced the first patient enrollment in the U.S. SALUS clinical trial ...
September 9, 2013 — Keystone Heart, a company in the development of cerebral protection devices for interventional ...
August 30, 2013 — PFM Medical received U.S. Food and Drug Administration (FDA) premarket approval (PMA) for its Nit ...
August 27, 2013 — Edwards Lifesciences Corp. announced that Japan's Central Social Insurance Medical Council (Chuikyo) ...
August 26, 2013 — JenaValve Technology Inc. has successfully completed the first two implantations of its second ...
August 22, 2013 – BioVentrix announced the successful first use of its Revivent Myocardial Anchoring System via the Less ...
August 14, 2013 — Colibri Heart Valve LLC announced that enrollment its first-in-human feasibility clinical study is ...
August 7, 2013 — W. L. Gore & Associates announced a favorable ruling involving the Gore Helex Septal Occluder. The Hon ...
August 6, 2013 — Edwards Lifesciences received conditional investigational device exemption (IDE) approval from the U.S ...